206
Views
0
CrossRef citations to date
0
Altmetric
COMMENTARY

Advances in Polatuzumab Vedotin-PIIQ Therapy: A Review of Treatment Efficacy in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 323-331 | Received 06 Jul 2023, Accepted 13 Oct 2023, Published online: 16 Oct 2023